Results
1 -
10 of
40
(Click
here to explore results)
- Anti-cooperative ligand binding and dimerisation in the glycopeptide antibiotic dalbavancin. Mu Cheng, Zyta M. Ziora, Karl A. Hansford, Mark A. Blaskovich, Mark S. Butler, Matthew A. Cooper
, Org. Biomol. Chem.
, 2014
, 12
, 2568
- Bacterial lipid membranes as promising targets to fight antimicrobial resistance, molecular foundations and illustration through the renewal of aminoglycoside antibiotics and emergence of amphiphilic aminoglycosides. Marie-Paule Mingeot-Leclercq, Jean-Luc Décout
, Med. Chem. Commun.
, 2016
, 7
, 586
- Cyclic peptide drugs approved in the last two decades (2001–2021). Huiya Zhang, Shiyu Chen
, RSC Chem. Biol.
, 2022
, 3
, 18
- A review on cell wall synthesis inhibitors with an emphasis on glycopeptide antibiotics. Paramita Sarkar, Venkateswarlu Yarlagadda, Chandradhish Ghosh, Jayanta Haldar
, Med. Chem. Commun.
, 2017
, 8
, 516
- Targeting membrane-bound bacterial cell wall precursors: a tried and true antibiotic strategy in nature and the clinic. Ned P. Buijs, Eilidh J. Matheson, Stephen A. Cochrane, Nathaniel I. Martin
, Chem. Commun.
, 2023
, 59
, 7685
- Targeting a cell wall biosynthesis hot spot. Anna Müller, Anna Klöckner, Tanja Schneider
, Nat. Prod. Rep.
, 2017
, 34
, 909
- Natural products acting against S. aureus through membrane and cell wall disruption. Gautam Kumar, Kritika Engle
, Nat. Prod. Rep.
, 2023
, 40
, 1608
- Next-generation membrane-active glycopeptide antibiotics that also inhibit bacterial cell division. Paramita Sarkar, Kathakali De, Malvika Modi, Geetika Dhanda, Richa Priyadarshini, Julia E. Bandow, Jayanta Haldar
, Chem. Sci.
, 2023
, 14
, 2386
- Natural product and natural product derived drugs in clinical trials. Mark S. Butler, Avril A. B. Robertson, Matthew A. Cooper
, Nat. Prod. Rep.
, 2014
, 31
, 1612
- Recent advances in the synthesis of new glycopeptide antibiotics. Polly-Anna Ashford, Sean P. Bew
, Chem. Soc. Rev.
, 2012
, 41
, 957